ATE489391T1 - Neue 4-amino-3-(-azolylphenoxymethyl)thienoä3,2- cüpyridin-7-carbonsäurederivate - Google Patents

Neue 4-amino-3-(-azolylphenoxymethyl)thienoä3,2- cüpyridin-7-carbonsäurederivate

Info

Publication number
ATE489391T1
ATE489391T1 AT07730300T AT07730300T ATE489391T1 AT E489391 T1 ATE489391 T1 AT E489391T1 AT 07730300 T AT07730300 T AT 07730300T AT 07730300 T AT07730300 T AT 07730300T AT E489391 T1 ATE489391 T1 AT E489391T1
Authority
AT
Austria
Prior art keywords
thienoä3
cupyridine
azolylphenoxymethyl
amino
new
Prior art date
Application number
AT07730300T
Other languages
English (en)
Inventor
Yi Chen
Kin-Chun Thomas Luk
Pamela Loreen Rossman
Sung-Sau So
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE489391T1 publication Critical patent/ATE489391T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Materials For Medical Uses (AREA)
AT07730300T 2006-06-29 2007-06-22 Neue 4-amino-3-(-azolylphenoxymethyl)thienoä3,2- cüpyridin-7-carbonsäurederivate ATE489391T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81761606P 2006-06-29 2006-06-29
PCT/EP2007/056241 WO2008000697A1 (en) 2006-06-29 2007-06-22 Novel 4-amino-3-(-azolyl-phenoxymethyl)-thieno[3,2]pyridine-7-carboxylic acid derivatives

Publications (1)

Publication Number Publication Date
ATE489391T1 true ATE489391T1 (de) 2010-12-15

Family

ID=38514272

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07730300T ATE489391T1 (de) 2006-06-29 2007-06-22 Neue 4-amino-3-(-azolylphenoxymethyl)thienoä3,2- cüpyridin-7-carbonsäurederivate

Country Status (16)

Country Link
US (1) US7932390B2 (de)
EP (1) EP2038288B1 (de)
JP (1) JP4933617B2 (de)
KR (1) KR101143286B1 (de)
CN (1) CN101479278B (de)
AT (1) ATE489391T1 (de)
BR (1) BRPI0713041A8 (de)
CA (1) CA2655398C (de)
DE (1) DE602007010779D1 (de)
DK (1) DK2038288T3 (de)
ES (1) ES2354637T3 (de)
IL (1) IL195897A (de)
MX (1) MX2008016068A (de)
PL (1) PL2038288T3 (de)
PT (1) PT2038288E (de)
WO (1) WO2008000697A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9540322B2 (en) 2008-08-18 2017-01-10 Yale University MIF modulators
EP2550266B1 (de) 2010-03-24 2018-05-09 Amitech Therapeutics Solutions, Inc. Heterozyklische verbindungen zur kinasehemmung
KR20230153387A (ko) 2021-02-02 2023-11-06 리미널 바이오사이언시스 리미티드 Gpr84 길항제 및 이의 용도
JP2024506858A (ja) 2021-02-02 2024-02-15 リミナル・バイオサイエンシーズ・リミテッド Gpr84アンタゴニストおよびその使用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2732970B1 (fr) 1995-04-14 1997-05-16 Hoechst Schering Agrevo Sa Nouveaux derives de l'acide beta-methoxy acrylique, leur procede de preparation et leur application comme pesticides
UA60365C2 (uk) 1998-06-04 2003-10-15 Пфайзер Продактс Інк. Похідні ізотіазолу, спосіб їх одержання, фармацевтична композиція та спосіб лікування гіперпроліферативного захворювання у ссавця
US6232320B1 (en) 1998-06-04 2001-05-15 Abbott Laboratories Cell adhesion-inhibiting antiinflammatory compounds
HN2000000051A (es) 1999-05-19 2001-02-02 Pfizer Prod Inc Derivados heterociclicos utiles como agentes anticancerosos
MXPA03004714A (es) 2000-11-28 2003-08-19 Pfizer Prod Inc Sales de una isotiazol-4-carboxamida y su uso como agentes de antihiperproliferacion.
MXPA04009541A (es) 2002-03-29 2005-01-25 Chiron Corp Benzazoles sustituidos y uso de los mismos como inhibidores de cinasa raf.
EP1556053A4 (de) 2002-10-31 2006-04-19 Amgen Inc Entzündungshemmende mittel
US7592352B2 (en) 2003-05-06 2009-09-22 Smithkline Beecham Corporation Substituted thieno and furo-pyridines
US20050020619A1 (en) 2003-07-24 2005-01-27 Patrick Betschmann Thienopyridine kinase inhibitors
US20050026944A1 (en) 2003-07-24 2005-02-03 Patrick Betschmann Thienopyridine and furopyridine kinase inhibitors
US7202363B2 (en) 2003-07-24 2007-04-10 Abbott Laboratories Thienopyridine and furopyridine kinase inhibitors
WO2005056562A1 (en) 2003-12-05 2005-06-23 Boehringer Ingelheim Pharmaceuticals, Inc. Substituted 3-amino-thieno[2,3-b] pyridine-2-carboxylic acid amide compounds as ikk inhibitors
US20050256154A1 (en) 2004-05-04 2005-11-17 Kin-Chun Luk 4-Amino-thieno[3,2-c]pyridine-7-carboxylic acid amides

Also Published As

Publication number Publication date
KR20090021195A (ko) 2009-02-27
CA2655398C (en) 2014-07-29
WO2008000697A1 (en) 2008-01-03
MX2008016068A (es) 2009-01-15
BRPI0713041A8 (pt) 2019-01-15
BRPI0713041A2 (pt) 2012-04-17
CN101479278B (zh) 2011-12-07
DK2038288T3 (da) 2011-01-03
ES2354637T3 (es) 2011-03-16
US20080009515A1 (en) 2008-01-10
PT2038288E (pt) 2011-01-12
EP2038288B1 (de) 2010-11-24
JP4933617B2 (ja) 2012-05-16
KR101143286B1 (ko) 2012-05-24
IL195897A (en) 2016-04-21
DE602007010779D1 (en) 2011-01-05
IL195897A0 (en) 2009-09-01
US7932390B2 (en) 2011-04-26
AU2007263770A1 (en) 2008-01-03
JP2009541424A (ja) 2009-11-26
EP2038288A1 (de) 2009-03-25
CA2655398A1 (en) 2008-01-03
CN101479278A (zh) 2009-07-08
PL2038288T3 (pl) 2011-05-31

Similar Documents

Publication Publication Date Title
MX2009004766A (es) Derivados de espiroindolinona.
MX2009012345A (es) Derivados de 3,3-espiroindolinona.
BRPI0717266A2 (pt) Derivados de oxindol
ECSP10010722A (es) Compuestos orgánicos
ATE495176T1 (de) Spiroindolinon-derivate
BRPI0821255A2 (pt) Derivados de espiroindolinona
MX341133B (es) Compuestos y metodos para la inhibición de hdac.
ATE528290T1 (de) Spiroindolinon-derivate
TNSN08407A1 (en) Organic compounds
UY30881A1 (es) Derivados de fenotiazina, procedimientos y su uso como productos farmacéuticos
WO2008107478A8 (en) Quinolinone derivatives as parp and tank inhibitors
AU2008303600A8 (en) 1,1,1-trifluoro-2-hydroxy-3-phenylpropane derivatives
EA201000544A1 (ru) Производные спирогетероциклического пирролидиндиона, применимые в качестве пестицидов
TN2011000286A1 (en) Spiroheterocyclic n-oxypiperidines as pesticides
TW200738695A (en) Cis-4,5-biaryl-2-heterocyclic-imidazolines as MDM2 inhibitors
MX2011008176A (es) Derivados de 3,3'-espiroindolinona como agentes anticancerigenos.
MY153763A (en) Quinazolinedione derivatives, preparation thereof and therapeutic uses thereof
MX2012006805A (es) Indolil-piperidinil bencilaminas como inhibidores de beta-triptasa.
BRPI0812222A2 (pt) Compostos ciclobutenodiona substituídos anti-inflamatórios.
GB0521508D0 (en) Organic compounds
EP2578587A4 (de) Pyrazolderivate
DE602007013077D1 (de) Organische verbindungen
MY146671A (en) Tetrahydronaphthaline derivatives, methods for the production and use thereof as anti-inflammatory agents
MX2009006337A (es) Analogos de epotilona modificados en las posiciones c12-c13, como farmacos contra el cancer.
WO2008019030A3 (en) Modified azole compounds as antiinfective agents

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 2038288

Country of ref document: EP